Learn More
Medchemexpress LLC Atazanavir (sulfate) | 229975-97-7 | 99.7% | 802.93 | 50 MG

Supplier: Medchemexpress LLC HY17367A50MG
Atazanavir sulfate is a highly selective and orally active HIV-1 protease inhibitor with blood-brain barrier permeability. It functions as both a substrate and inhibitor of CYP3A4, and also inhibits P-glycoprotein (P-gp). Additionally, it is a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. This compound has demonstrated the ability to inhibit cardiac fibrosis and hyperlipidemia, and induce malignant glioma cell death.
- Highly selective and orally active
- HIV-1 protease inhibitor
- Crosses the blood-brain barrier
- Inhibitor and substrate of CYP3A4
- Inhibits P-glycoprotein (P-gp)
- SARS-CoV 3CLpro inhibitor (IC50 of 3.49 μM)
- Inhibits cardiac fibrosis
- Inhibits hyperlipidemia
- Induces malignant glioma cell death
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.